Amniotic epithelial stem cells (AEC) hold potential for tissue regeneration, especially through their conditioned medium (AEC-CM) due to their immunomodulatory and regenerative effects. Nevertheless, advanced drug delivery systems such as hydrogels are needed to enable clinical applications. Herein, an gellable hyaluronic acid and polyethylene glycol-based iEDDA-cross-linked hydrogel was developed for the encapsulation and controlled release of AEC-CM. The developed system was formed by norbornene-modified hyaluronic acid and tetrazine-modified polyethylene glycol functionalized with heparin. The hydrogel was formed by mixing both precursor polymers, displaying fast cross-linking kinetics and showcasing a highly porous inner structure and low swelling properties. Moreover, the heparin-functionalized system allowed the sustained release of predominant growth factors from AEC-CM over 14 days. studies in peripheral blood mononuclear cells (PBMCs) showed an enhanced suppression efficacy and a significant shift toward the M2 macrophage phenotype in comparison with nonencapsulated AEC-CM. Therefore, this work provides a suitable alternative for the encapsulation of AEC-CM in a hydrogel formulation, highlighting its potential as an alternative immunomodulatory therapeutic tool for tissue regeneration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.4c16659 | DOI Listing |
Hum Cell
January 2025
Department of Metabolism and Endocrinology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
The escalating diabetes prevalence has heightened interest in innovative therapeutic strategies for this disease and its complications. Human amniotic epithelial stem cells (HAESCs), originate from the innermost layer of the placenta closest to the fetus and express stem cell markers in the amniotic membrane's umbilical cord attachment area, which have garnered significant attention. This article critically examines emerging research advancements and potential application values of hAESCs in treating diabetes and its complications.
View Article and Find Full Text PDFACS Appl Mater Interfaces
January 2025
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, 00014 Helsinki, Finland.
Cureus
November 2024
Ophthalmology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, JPN.
We report a case of sympathetic ophthalmia that developed in the fellow eye following therapeutic corneal transplantation and amniotic membrane transplantation for corneal perforation caused by corneal ulceration. A 62-year-old man presented with discharge, lacrimation, and decreased visual acuity in the left eye. He was diagnosed with a corneal ulcer and treated with antimicrobial agents, but corneal epithelial erosion persisted, leading to nontraumatic corneal perforation.
View Article and Find Full Text PDFIndian J Ophthalmol
December 2024
Department of Ophthalmology, Military Hospital, Panagarh, West Bengal, India.
We describe a novel technique for recurrent pterygium and assess the advantage of properties of extended tenonectomy, amniotic membrane transplantation, and limbal epithelial transplantation in terms of recurrence rate, postoperative symptoms, postoperative orthoptics, and other complications. A total of nine eyes with recurrent pterygium underwent PERMISLET, i.e.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
December 2024
Hariram Motumal Nasta & Renu Hariram Nasta Ophthalmic Plastic Surgery Services, KAR Campus.
Purpose: To evaluate the growth, management, and outcomes of epibulbar dermolipomas over a 5-year follow-up period.
Methods: This was a retrospective chart review of epibulbar dermolipoma patients with a minimum follow-up of 5 years, which analyzed the changes in size, refractive errors (spherical equivalent), best-corrected visual acuity, histology, and surgical outcomes.
Results: A total of 61 eyes of 53 patients (32 females) with an average presenting age of 4.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!